China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)
天津天药药业股份有限公司等3家企业
Why it is here
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — cartel (monopoly agreement) (津市监垄处〔2021〕1号; 津市监垄处〔2021〕2号; 津市监垄处〔2021〕3号 · 市场监管总局发布天津天药药业股份有限公司等3家企业达成并实施垄断协议案行政处罚决定书), from 30 April 2021.
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Cartel (monopoly agreement).
Details
- Company
- 天津天药药业股份有限公司等3家企业
- Authority
- State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
- Decision
- Cartel (monopoly agreement)
- Grounds and details, as published
- 津市监垄处〔2021〕1号; 津市监垄处〔2021〕2号; 津市监垄处〔2021〕3号 · 市场监管总局发布天津天药药业股份有限公司等3家企业达成并实施垄断协议案行政处罚决定书
- From
- 30 April 2021
- Until
- —
- Status
- End date not published
- Source
- https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_b6d0654a19d24036aae7993726c8248e.html
- Licence
- Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)
SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)